✦ LIBER ✦

Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies

✍ Scribed by Peter Ragnhammar; Jan Fagerberg; Jan-Erik Frödin; Peter Wersäll; Lars-Olof Hansson; Hakan Mellstedt

Book ID: 105229596
Publisher: Springer-Verlag
Year: 1995
Tongue: English
Weight: 889 KB
Volume: 40
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01525387

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytotoxicity of white blood cells activa

Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies

✍ P. Ragnhammar; J. -E. Frödin; P. P. Trotta; H. Mellstedt 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 935 KB

Granulocyte-monocyte-colony-stimulating

Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity

✍ G. Masucci; P. Wersäll; P. Ragnhammar; H. Mellstedt 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 503 KB

Human peripheral blood mononuclear cells (lymphocytes and monocytes) were preincubated for 0-24 h with human recombinant granulocyte-monocyte-colony-stimulating factor (GM-CSF) and used as effector cells in an 18 h antibody-dependent cellular cytotoxicity (ADCC) assay with SW948 (a human colorectal

Transduction of the Macrophage Colony-st

Transduction of the Macrophage Colony-stimulating Factor Gene into Human Multidrug Resistant Cancer Cells: Enhanced Therapeutic Efficacy of Monoclonal Anti-P-glycoprotein Antibody in Nude Mice

✍ Sone, Saburo ;Tsuruo, Takashi ;Sato, Shigeo ;Yano, Seiji ;Nishioka, Yasuhiko ;Sh 📂 Article 📅 1996 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 498 KB

Granulocyte-monocyte colony-stimulating-

Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A)

✍ Giuseppe Masucci; Peter Ragnhammar; Peter Wersäll; Håkan Mellstedt 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 640 KB

Clinical effects of monoclonal antibody

Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma

✍ A.-L. Hjelm Skog; P. Ragnhammar; J. Fagerberg; J.-E. Frödin; M. Goldinger; H. Ko 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 215 KB

A phase I study of anti-GD3 ganglioside

A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma

✍ Lori M. Minasian; Tzy Jyun Yao; Thomas A. Steffens; David A. Scheinberg; Linda W 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB